Innovo Research and Pinehurst Medical Clinic Announce Strategic Partnership to Advance Clinical Trials

January 14, 2025 11:52 PM MSK | By EIN Presswire
 Innovo Research and Pinehurst Medical Clinic Announce Strategic Partnership to Advance Clinical Trials
Image source: EIN Presswire
WILMINGTON, NC, UNITED STATES, January 14, 2025 /EINPresswire.com/ -- Innovo Research and Pinehurst Medical Clinic (PMC) are excited to announce a strategic partnership designed to bring clinical trial opportunities to patients in the Pinehurst, NC region. Through this collaboration, Innovo Research will serve as the exclusive Integrated Research Organization (IRO) for Pinehurst Medical Clinic, enhancing its capacity to conduct cutting-edge clinical research while maintaining its longstanding commitment to high-quality patient care.

The partnership reflects a shared vision of leveraging clinical trials to advance medical care and improve patient outcomes. By combining Pinehurst Medical Clinic’s comprehensive healthcare expertise with Innovo Research’s proven site management capabilities, the organizations will streamline the integration of clinical research into PMC’s existing care framework.

As part of this collaboration, Pinehurst Medical Clinic will benefit from Innovo Research’s expertise in operationalizing clinical trials, including patient enrollment, trial oversight, and regulatory compliance. Jeff James, CEO of Innovo Research, expressed enthusiasm, stating, “This partnership will further support Pinehurst Medical Clinic’s role as an Accountable Care Organization (ACO), enabling the clinic to improve patient outcomes and reduce healthcare costs by integrating research-driven insights into its care delivery model.” Patients at PMC will also have expanded access to advanced clinical trials across various therapeutic areas, ranging from early-phase investigations to late-stage studies.

Brandon Enfinger, CEO of Pinehurst Medical Clinic, echoed this sentiment saying, “The partnership between Innovo Research and Pinehurst Medical Clinic underscores a commitment to advancing healthcare through quality, compassion, and innovation. Together, the organizations will foster a culture of excellence in clinical research, ensuring patients receive exceptional care while contributing to the development of life-changing treatments”

The partnership signifies a meaningful next step in the evolution of health care, where research and patient care converge to create a more efficient, accessible, and patient-focused approach. For more information about this collaboration and the services offered by Pinehurst Medical Clinic and Innovo Research, please visit www.pinehurstmedical.com and www.innovoresearch.com.

About Innovo Research
Innovo Research is a trusted Site Management Organization (SMO) dedicated to advancing clinical trials by operationalizing research and providing exceptional patient care. With core values rooted in quality, compassion, and innovation, Innovo Research partners with healthcare organizations to streamline clinical research and improve access to groundbreaking therapies.
Media Contact:
Halley Losekamp
[email protected]

About Pinehurst Medical Clinic
Pinehurst Medical Clinic is a recognized healthcare provider in the communities of Moore County, Lee County, Cumberland County, Chatham County and the surrounding six counties. Locally owned and managed, Pinehurst Medical Clinic offers a broad range of primary and specialty care services to the communities we serve. The physicians and healthcare team of professionals at Pinehurst Medical Clinic share a commitment to patient-centered care that is physician-led and utilizes the latest advances in medical technology. This combination of leading-edge medicine and deep compassion for the people we serve has been a hallmark of the Pinehurst Medical Clinic since 1952. Pinehurst Medical Clinic consists of over 160 providers, approximately 950 employees, and 16 locations.
Media Contact:
Nichole Esowski
[email protected]

Halley Losekamp
Innovo Research
[email protected]
Visit us on social media:
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.